As a component of the RNA‐induced silencing complex, SND1 is reported to be highly expressed in human colon cancers and implicated in early‐stage colon carcinogenesis by participating in the posttranscriptional modifications of APC and ß‐catenin 50. This evidence concerns the gene SND1 and malignant colon neoplasm.